BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36636075)

  • 1. PRRX1 promotes colorectal cancer stemness and chemoresistance via the JAK2/STAT3 axis by targeting IL-6.
    Zhong L; Tan W; Yang Q; Zou Z; Zhou R; Huang Y; Qiu Z; Zheng K; Huang Z
    J Gastrointest Oncol; 2022 Dec; 13(6):2989-3008. PubMed ID: 36636075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological targeting PTK6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer.
    Liu C; Pan Z; Chen Q; Chen Z; Liu W; Wu L; Jiang M; Lin W; Zhang Y; Lin W; Zhou R; Zhao L
    J Exp Clin Cancer Res; 2021 Sep; 40(1):297. PubMed ID: 34551797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA FEZF1-AS1 promotes colorectal cancer progression through regulating the miR-363-3p/PRRX1 pathway.
    Zhang T; Yu S; Zhao S
    Adv Clin Exp Med; 2021 Aug; 30(8):839-848. PubMed ID: 34286520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
    Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
    Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-Specific Peptidase 22 Contributes to Colorectal Cancer Stemness and Chemoresistance via Wnt/β-Catenin Pathway.
    Jiang S; Song C; Gu X; Wang M; Miao D; Lv J; Liu Y
    Cell Physiol Biochem; 2018; 46(4):1412-1422. PubMed ID: 29689565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer.
    Primeaux M; Liu X; Gowrikumar S; Fatima I; Fisher KW; Bastola D; Vecchio AJ; Singh AB; Dhawan P
    Cancer Lett; 2023 Nov; 579():216479. PubMed ID: 37924938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-124 Radiosensitizes human colorectal cancer cells by targeting PRRX1.
    Zhang Y; Zheng L; Huang J; Gao F; Lin X; He L; Li D; Li Z; Ding Y; Chen L
    PLoS One; 2014; 9(4):e93917. PubMed ID: 24705396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
    Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
    Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway.
    Wang X; Sun D; Tai J; Chen S; Yu M; Ren D; Wang L
    J Exp Clin Cancer Res; 2018 Feb; 37(1):27. PubMed ID: 29439714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer.
    Zhu Y; Huang S; Chen S; Chen J; Wang Z; Wang Y; Zheng H
    Cell Death Dis; 2021 May; 12(5):449. PubMed ID: 33953166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway.
    Ren D; Lin B; Zhang X; Peng Y; Ye Z; Ma Y; Liang Y; Cao L; Li X; Li R; Sun L; Liu Q; Wu J; Zhou K; Zeng J
    Oncotarget; 2017 Jul; 8(30):49807-49823. PubMed ID: 28591704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paired related homoeobox 1, a new EMT inducer, is involved in metastasis and poor prognosis in colorectal cancer.
    Takahashi Y; Sawada G; Kurashige J; Uchi R; Matsumura T; Ueo H; Takano Y; Akiyoshi S; Eguchi H; Sudo T; Sugimachi K; Doki Y; Mori M; Mimori K
    Br J Cancer; 2013 Jul; 109(2):307-11. PubMed ID: 23807160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis.
    Jiang S; Miao D; Wang M; Lv J; Wang Y; Tong J
    J Cell Mol Med; 2019 Jan; 23(1):630-640. PubMed ID: 30338942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway.
    Zhang C; Ma K; Li WY
    J Cancer; 2019; 10(26):6511-6525. PubMed ID: 31777581
    [No Abstract]   [Full Text] [Related]  

  • 15. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.
    Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L
    Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficient or R273H and R248W Mutations of p53 Promote Chemoresistance to 5-FU
    Gao X; Zheng X; Zhang Y; Dong L; Sun L; Zhao N; Ding C; Ma Z; Wang Y
    Front Cell Dev Biol; 2021; 9():788331. PubMed ID: 35071232
    [No Abstract]   [Full Text] [Related]  

  • 17. Prrx1 promotes stemness and angiogenesis via activating TGF-β/smad pathway and upregulating proangiogenic factors in glioma.
    Chen Z; Chen Y; Li Y; Lian W; Zheng K; Zhang Y; Zhang Y; Lin C; Liu C; Sun F; Sun X; Wang J; Zhao L; Ke Y
    Cell Death Dis; 2021 Jun; 12(6):615. PubMed ID: 34131109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer.
    Yuan W; Ji J; Shu Y; Chen J; Liu S; Wu L; Zhou Z; Liu Z; Tang Q; Zhang X; Shu X
    J Mol Med (Berl); 2019 Jan; 97(1):89-102. PubMed ID: 30460377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA Paired-Related Homeobox 1 Promotes Gastric Carcinoma Cell Progression via Regulating MicroRNA-665/YWHAZ Axis.
    Liu W; Hu W; Hou K; Zhu S
    Dig Dis Sci; 2021 Nov; 66(11):3842-3853. PubMed ID: 33201331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637.
    Zhang Y; Li C; Liu X; Wang Y; Zhao R; Yang Y; Zheng X; Zhang Y; Zhang X
    EBioMedicine; 2019 Oct; 48():277-288. PubMed ID: 31631038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.